Valuation
- Market cap
- 8,819,000
- Revenue TTM
- $0
- Net income TTM
- $-7,030,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 39,700
- Avg volume
- 36,226
- Day's range
- $5.91 – $6.11
- Shares out
- 1,500,000
- Stochastic %K
- 38%
- Beta
- -0.09
- Analysts
- Sell
- Price target
- $25.00
Company profile
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as...
Show more
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
- Industry
- Diagnostics & Research
- Sector
- Healthcare
- Phone
- 734 335 0468
- Website
- https://endrainc.com
- Address
- 3600 Green Court, Suite 350, Ann Arbor, United States
Latest news
No headlines yet.
